Hasanin Khachi MRPharmS IPresc Dip Clin Pharm is a respiratory pharmacist at Barts Health NHS Trust.
Asthma and chronic obstructive pulmonary disease (COPD) continue to account for a large burden of disease in the UK. Despite comprehensive guidelines, more than 1,000 people die from asthma each year and COPD accounts for a leading cause of emergency admissions in the UK. In a joint initiative between NHS City and Hackney clinical commissioning group and the local tertiary centre for respiratory disease Barts Health NHS Trust, asthma and COPD reviews were undertaken by a specialist respirator
Improving outcomes for COPD patientsSubscription
An initiative to improve COPD care at Barts Health NHS Trust in London has led to improved health outcomes.
The UK is experiencing an explosion of new drugs and inhaler devices being licensed for people with respiratory disease, increasing the complexity of prescribing for people with asthma or chronic obstructive pulmonary disease (COPD). The management of how these new products are introduced into clinical practice is important because they may vary in type of inhaler device and licensing. One product is DuoRespSpiromax, a cheaper “branded generic” of Symbicort Turbohaler, both containing
Asthma: long-term managementSubscription
Asthma: pathophysiology, causes and diagnosisSubscription
Primum non nocereSubscription
Our concerns with Relvar ElliptaSubscription
High blood pressure? Consider hyperaldosteronismSubscription